Comparison

Lung Cancer Screening Guide vs PLCOm2012 LCRC

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Lung Cancer Screening Guide

This clinical decision-support tool helps healthcare professionals categorize lung nodules and determine follow-up actions based on ACR Lung-RADS v2022 guidelines. It offers step-by-step guidance, real-time score updates, and integration of incidental findings for consistent application of recommendations.

Highlights
  • ACR Lung-RADS v2022 Integration
  • Dynamic Lung-RADS Card
  • S Modifier Integration
  • Comprehensive Nodule Insights
  • Self-Assessment Mode
  • Brock (Full Model) Calculator
  • Offline Access
Features
Read full description

Download includes a free trial; continued use requires a 6‑ or 12‑month auto‑renewing subscription. Lung Cancer Screening Guide is a clinical decision‑support tool built around ACR Lung‑RADS v2022, including the new “S” modifier for clinically significant incidental findings. The app delivers step‑by‑step guidance at the point of care, streamlining lung‑nodule categorization and follow‑up so you can apply standardized recommendations with clarity and consistency—whether you practice in radiology, pulmonology, or primary care. --- Key Features (unlocked after the free trial with an active subscription) ACR Lung‑RADS v2022 Integration • Full, in‑app access to every Lung‑RADS category (0–4X) plus the “S” modifier, with concise management instructions drawn directly from the guidelines. Dynamic Lung‑RADS Card • A single, color‑coded card that updates your Lung‑RADS score in real time as you enter screening round, nodule morphology, size, and growth—making classification fast. S Modifier Integration • Toggle clinically significant findings across organ systems (e.g., coronary calcium, thyroid nodule, liver lesion) and instantly receive tailored, ACR‑based follow‑up recommendations sourced from the ACR Incidental Findings White Papers. Comprehensive Nodule Insights • Practical guidance on measuring nodules, stepped management pathways, etc. Self-Assessment Mode • Expert-curated self-assessment question packs. Brock (Full Model) Calculator • Calculate a CT-detected nodule’s 2–4 year malignancy risk. Enhanced Readability • Dark‑mode support, dynamic text sizing, and a distraction‑free interface optimized for hectic reading environments. Offline Access • All guideline logic run on‑device—no login or server needed. Medical Disclaimer: This app is for informational purposes only and is not a substitute for professional medical advice. In addition to using this app, always consult a qualified healthcare provider for diagnosis and treatment decisions. SUBSCRIPTION OPTIONS ¹ • 6‑Month subscription (free trial available) | Price displayed in‑app; may vary by region • 12‑Month subscription (free trial available) | Price displayed in‑app; may vary by region We strive to incorporate any updates to ACR Lung‑RADS or S Modifier guidance within 30 days of publication and plan to add new self‑assessment question packs every six months. Future feature additions and update frequency may change without notice. ¹ Payment & Renewal – Payment is charged to your Apple ID at confirmation. Subscriptions renew automatically unless auto-renew is turned off at least 24 hours before the end of the current period. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions. Note: If you switch plans or re-subscribe during the free trial, the remaining trial time is lost and you will be charged immediately. Privacy Policy: https://radiologiq.squarespace.com/privacy Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

About

PLCOm2012 LCRC

Features
Read full description

This app is for use by people who currently smoke or used to smoke. It is a lung cancer risk calculator. It calculates your six-year risk of developing lung cancer based on your age, formal education, height and weight, family history of lung cancer, your cancer and lung health history, and your smoking history. There are two versions of the app. The only difference is one version, PLCOm2012 includes race as an input and the other version, PLCOm2012noRace does not have race as an input. The PLCOm2012noRace version is appropriate for use outside of the United States. You can take the risk calculated by this app to your health care professional and discuss if you should be screened for lung cancer and to see if you are eligible for screening in your area. This app can also be used by health care professionals with their patients to assess risk of lung cancer in a shared decision-making discussion about the benefits and potential risks of screening. The calculator is based on the PLCOm2012 lung cancer risk prediction model developed by Professor Martin Tammemägi. It has been validated by many researchers in multiple countries and is used in lung cancer screening studies, pilots and programs around the world. The PLCOm2012 app version has been simplified by reducing race/ethnic categories from 7 to 3. The PLCOm2012noRace app has been simplified by taking race out as an input. Performance of the modified models are almost identical to the initial model and in some measures are improved. Any information you enter into this application will only be stored on your device while you are using the risk calculator. All input fields will be reset after you exit the app. The PLCOm2012 and PLCOm2012noRace LCRC apps work off-line and do not use internet connections. Your personal information is not collected or stored anywhere outside of your smartphone, so it is not possible for your information to be shared with others. The PLCOm2012 and PLCOm2012noRace LCRC apps were developed as a public service by epidemiologist Martin Tammemägi DVM, MSc, PhD and patient advocate Andrea Borondy Kitts MS, MPH. They are provided free of charge and free of advertising to the general public and the medical community. Disclaimer The content of the PLCOm2012 and PLCOm2012noRace LCRC apps are based on scientific research. But information provided here should not be substituted for a physician’s evaluation, advice, diagnosis or treatment. Your doctor is the most appropriate person to provide you with guidance on specific health issues. If you are currently ill or have symptoms, seek the help of your health care provider. If you currently smoke, one of the most important health decisions you can make, is to quit smoking. Your doctor should be able to help you quit more successfully. No cancer prediction model is 100% accurate. It is important to appreciate that some individuals with low predicted risks will develop lung cancer, and not all individuals with high risk scores will develop lung cancer. We provide the PLCOm2012 and PLCOm2012noRace Lung Cancer Risk Calculators apps (PLCOm2012 and PLCOm2012noRace LCRC apps) as a public service only and you use them at your own risk.

Screenshots

Lung Cancer Screening Guide4 screens
PLCOm2012 LCRC4 screens

Verdict

The call

The clearest difference is in-app purchases: PLCOm2012 LCRC at none against Lung Cancer Screening Guide's 2. On price, update cadence, ads and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Lung Cancer Screening Guide sells 2 in-app purchases, starting at $9.99 per 6 months. PLCOm2012 LCRC asks for nothing beyond the download.

UpkeepUpdate frequency

Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on October 24, 2026 and October 16, 2026 respectively.

Scorecard1 real difference · 9 level
Lung Cancer Screening Guide versus PLCOm2012 LCRC: the parameters behind the verdict, then further details
ParameterLung Cancer Screening GuidePLCOm2012 LCRC
PriceFreeFree
Rating4.8 (17 ratings) — better—
Positive reviews100.0% of reviews—
Number of ratings17 — better—
Update frequencyEvery 2 monthsEvery 2 months
AdsNoNo
In-app purchasesYesNo — better
MonetizationSubscription—
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS16.615.1 — better
Further details — not scored
Size65 MB38 MB
Age rating12+4+
DeveloperRADIOLOGiQ, LLCBlue Pony Digital

In-app purchases

2 purchases

Lung Cancer Screening Guide

Subscriptions2
  • 6-Month Subscription14 Days trial$9.996 Months
  • 12-Month Subscription14 Days trial$14.991 Year
None

PLCOm2012 LCRC

No in-app purchases

Questions

Is Lung Cancer Screening Guide free?
Lung Cancer Screening Guide is free to download, with in-app purchases available.
Is PLCOm2012 LCRC free?
PLCOm2012 LCRC is free to download, with no in-app purchases.
Do Lung Cancer Screening Guide or PLCOm2012 LCRC have ads?
Neither Lung Cancer Screening Guide nor PLCOm2012 LCRC shows ads.
Which is updated more often, Lung Cancer Screening Guide or PLCOm2012 LCRC?
Lung Cancer Screening Guide ships an update every 2 months, and PLCOm2012 LCRC every 2 months. Most recently, Lung Cancer Screening Guide was updated on October 24, 2026 and PLCOm2012 LCRC on October 16, 2026.

Other comparisons